FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to pharmaceutical compositions containing synthetic oxidised lipids.
EFFECT: developing the method for using the oxidised lipids for treating and preventing the inflammation associated with the endogenous oxidised lipid.
39 cl, 11 tbl, 15 ex, 25 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| OXIDISED LIPIDS AND THEIR APPLICATION FOR TREATMENT OF INFLAMMATORY DISEASES AND DISTURBANCES | 2004 |
|
RU2362567C2 |
| OXIDISED LIPID COMPOUNDS AND THEIR APPLICATION | 2009 |
|
RU2532546C2 |
| METHOD FOR STRUCTURAL AND/OR FUNCTIONAL IMPROVEMENT OF ARTERIOLES | 2005 |
|
RU2414236C2 |
| IMPROVED METHOD FOR SYNTHESIS OF OXIDISED PHOSPHOLIPIDS | 2005 |
|
RU2399626C2 |
| PEGYLATED LIPID NANOPARTICLE WITH A BIOACTIVE LIPOPHILIC COMPOUND | 2016 |
|
RU2737893C2 |
| PEPTIDE POSSESSING ABILITY TO RELIEVE AT LEAST ONE SYMPTOM OF INFLAMMATORY CONDITION, PHARMACEUTICAL COMPOSITION CONTAINING IT AND METHOD OF TREATING ATHEROSCLEROSIS WITH THEIR APPLICATION | 2005 |
|
RU2448977C2 |
| EXTERNAL COMPOSITIONS CONTAINING ADENOSYL COBALAMIN FOR TREATMENT OF SKIN DISEASES | 2006 |
|
RU2379039C2 |
| LIPID COMPOUND AND COMPOSITION BASED THEREON | 2021 |
|
RU2825571C1 |
| DRUG CARRIER | 2008 |
|
RU2476204C2 |
| LIPOSOME-CONTAINING COMPOSITION | 2019 |
|
RU2777601C1 |
